Case Report: Successful Treatment of Pulmonary Talaromyces Marneffei Infection with Posaconazole in a Renal Transplant Recipient
Overview
Affiliations
Talaromyces marneffei (T. marneffei), formerly Penicillium marneffei, is a dimorphic fungus prevalent in Southeast Asia that can cause severe systemic infection, especially in immunocompromised patients. There are few reports about the use of posaconazole in T. marneffei infection. Here, we present a case of pulmonary T. marneffei infection in a renal transplant recipient. The patient responded rapidly to oral posaconazole administration but experienced serum creatinine fluctuation because of the interaction between posaconazole and immunosuppressants. Seven months after adjusting the dose of immunosuppressants, the patient recovered completely. Posaconazole is a potentially promising therapy for T. marneffei infection, but it should be administered under close monitoring.
Xing F, Deng C, Zou S, Tsang C, Lo S, Lau S Mycopathologia. 2024; 189(6):91.
PMID: 39387982 PMC: 11466905. DOI: 10.1007/s11046-024-00898-3.
Li K, Zhang Y, Zhang D, Chen Q, Fang X Front Immunol. 2024; 15:1430179.
PMID: 39315098 PMC: 11417000. DOI: 10.3389/fimmu.2024.1430179.
Yang S, Lou L, Ma S, Wang H, Rong L, Liu Y BMC Infect Dis. 2024; 24(1):473.
PMID: 38711014 PMC: 11071178. DOI: 10.1186/s12879-024-09351-8.
Endemic mycoses - are we making progress in management?.
Bahr N, Thompson 3rd G Curr Opin Infect Dis. 2023; 36(6):436-442.
PMID: 37755392 PMC: 10840811. DOI: 10.1097/QCO.0000000000000971.
An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease.
Zaongo S, Zhang F, Chen Y J Fungi (Basel). 2023; 9(6).
PMID: 37367583 PMC: 10301665. DOI: 10.3390/jof9060647.